Kestra Private Wealth Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Buy |
6,127
+868
| +17% | +$386K | 0.04% | 419 |
|
|
2025
Q1 | $2.55M | Sell |
5,259
-1,777
| -25% | -$862K | 0.04% | 396 |
|
|
2024
Q4 | $2.83M | Sell |
7,036
-5,825
| -45% | -$2.35M | 0.05% | 350 |
|
|
2024
Q3 | $5.98M | Buy |
12,861
+1,012
| +9% | +$471K | 0.11% | 208 |
|
|
2024
Q2 | $5.55M | Buy |
11,849
+5,448
| +85% | +$2.55M | 0.11% | 204 |
|
|
2024
Q1 | $2.68M | Buy |
6,401
+2,047
| +47% | +$856K | 0.06% | 309 |
|
|
2023
Q4 | $1.77M | Buy |
4,354
+1,150
| +36% | +$468K | 0.05% | 374 |
|
|
2023
Q3 | $1.11M | Buy |
3,204
+1,381
| +76% | +$480K | 0.04% | 434 |
|
|
2023
Q2 | $642K | Buy |
1,823
+280
| +18% | +$98.5K | 0.02% | 558 |
|
|
2023
Q1 | $486K | Buy |
1,543
+194
| +14% | +$61.1K | 0.02% | 608 |
|
|
2022
Q4 | $390K | Sell |
1,349
-8
| -0.6% | -$2.31K | 0.02% | 590 |
|
|
2022
Q3 | $393K | Sell |
1,357
-29
| -2% | -$8.4K | 0.02% | 567 |
|
|
2022
Q2 | $391K | Sell |
1,386
-97
| -7% | -$27.4K | 0.02% | 580 |
|
|
2022
Q1 | $387K | Sell |
1,483
-42
| -3% | -$11K | 0.02% | 660 |
|
|
2021
Q4 | $335K | Buy |
1,525
+397
| +35% | +$87.2K | 0.02% | 727 |
|
|
2021
Q3 | $205K | Sell |
1,128
-288
| -20% | -$52.3K | 0.01% | 843 |
|
|
2021
Q2 | $286K | Buy |
1,416
+78
| +6% | +$15.8K | 0.02% | 698 |
|
|
2021
Q1 | $288K | Buy |
+1,338
| New | +$288K | 0.02% | 609 |
|
|
2020
Q4 | – | Sell |
-825
| Closed | -$224K | – | 781 |
|
|
2020
Q3 | $224K | Buy |
+825
| New | +$224K | 0.02% | 571 |
|